Cargando…
Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone
Thrombotic microangiopathy (TMA) associated with injecting sustained-release oxymorphone, an opioid intended for oral use, has previously been reported. We report a case of TMA secondary to intravenous use of sustained-release oxycodone, and the first case to demonstrate relapsing disease due to per...
Autores principales: | Nataatmadja, Melissa, Divi, Dakshinamurthy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957719/ https://www.ncbi.nlm.nih.gov/pubmed/27478601 http://dx.doi.org/10.1093/ckj/sfw039 |
Ejemplares similares
-
An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019) -
Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab
por: Jin, Anna, et al.
Publicado: (2016) -
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
por: Brocklebank, Vicky, et al.
Publicado: (2017) -
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
por: Allinovi, Marco, et al.
Publicado: (2017) -
Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome
por: Groves, Andrew P., et al.
Publicado: (2016)